CRFR1‐Antagonism Ameliorates Early AD Pathology and Alters Stress‐Induced Changes in Pathology

CRFR1-antagonism has the potential to improve and may be beneficial for stress-induced AD pathogenesis in the early phases of AD.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.092978
Primary Topic
Stress Responses and Cortisol
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CRFR1‐Antagonism Ameliorates Early AD Pathology and Alters Stress‐Induced Changes in Pathology

Robert A. Rissman, Floyd Sarsoza, Maya Ellisman
Alzheimer s & Dementia
Stress Responses and Cortisol
article

CRFR1‐Antagonism Ameliorates Early AD Pathology and Alters Stress‐Induced Changes in Pathology

Robert A. Rissman, Floyd Sarsoza, Maya Ellisman
article en

Abstract

CRFR1-antagonism has the potential to improve and may be beneficial for stress-induced AD pathogenesis in the early phases of AD.

Alzheimer s & DementiaVol. 20(S1)
University of California San Diego (US), VA San Diego Healthcare System (US)
Openalex Percentile: Top 76%
Stress Responses and Cortisol
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CRFR1‐Antagonism Ameliorates Early AD Pathology and Alters Stress‐Induced Changes in Pathology — Robert A. Rissman, Floyd Sarsoza, et al. · Alzheimer s & Dementia (2024) | TGRS Research Map | TGRS